Thus, the transcriptional responses observed in the pre- and on-treatment biopsies are similar to the RNAseq data obtained from cell line models and supports a hypothesis that treatment with EGFR TKI induces inflammatory and IFN responses in patient lung tumors that derives from direct actions of the TKIs on the cancer cells. This evidence concerns the gene IFNA1 and cancer.